CERT vs OGN · rev $385.1M vs P/E 3.4, rev $6.40B
Certara Inc (CERT) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CERT currently screens at market cap $1.86B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CERT and OGN stock pages for the full models.
Not investment advice.